Clinical determination of tumor markers in patients with testicular seminoma
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
We analyzed the prognostic value of the results of the study HCG and LDH levels of tumor markers in patients with testicular seminoma before and after orchidectomy and during chemotherapy. A correlation between increased levels of markers and disease stage revealed, and the relationship between the frequency and decrease the progression of time negativation LDH after chemotherapy was found. Confirmed low predictive value of HCG and LDH in the first stages of the disease progression to diagnose.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Weissbach L. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study / L. Weissbach, R. Bussar(Maatz, K. Mann // Eur Urol. – 1997. – 32 (1). – P. 16– 22.
Mead GM. MRC/EORTC seminoma trial collaborators. Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up / GM. Mead, SD. Fossa, RT. Oliver et al. // J. Natl. Cancer Inst. – 2011. – 103 (3). – P. 241– 9.
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group // J Clin Oncol. – 1997. – 15 (2). – P. 594– 603.
Schmoll HJ. ESMO Guidelines Working Group. Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up / HJ. Schmoll, K. Jordan, R. Huddart at al. // Ann Oncol. – 2010. – 21 (5).
Gilligan TD. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors / TD. Gilligan, J. Seidenfeld, EM. Basch et al. // J.Clin.Oncol. – 2010. – 28 (20). – P. 3388– 404.
Albers P. European Association of Urology. EAU guidelines on testicular cancer: 2011 update / P. Albers, W. Albrecht, F. Algaba et al. // Eur Urol. – 2011.
